This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Title of project or programme
| Title of PI | Managing behavioural problems in nursing home residents with dementia |
Principal Investigators of project/programme grant
| Title | Forname | Surname | Institution | Country |
| Dr | Martin | Smalbrugge | VU Medical Center | Netherlands |
Address of institution of lead PI
| Institution | VU Medical Center |
| Street Address | Van der Boechorststraat 7 |
| City | Amsterdam |
| Postcode | 1081 BT |
Country
- Netherlands
Source of funding information
Netherlands Organisation for Health Research and Development (ZonMw)
Total sum awarded (Euro)
368173
Start date of award
1-3-2010
Total duration of award in months
48
The project/programme is most relevant to
- Alzheimer’s disease and other dementias
Keywords
Dementia; Behavioral problems; Antipsychotics; Neuroleptics; Nursing Homes; Costs-and-Cost-Analysis; Therapeutics; Quality-of-Life
Research abstract in English
Objective: to quantify cost-effectiveness of a multidisciplinary, guideline based, care program ‘managing behavior problems (BPs) in nursing home (NH) residents with dementia’. Study design: a longitudinal controlled study on 14 dementia special care units that, in a stepped wedge design, all will implement the program. Study population: all patients on participating units. Intervention: evidence based standardization of the management of BP in NH residents with dementia, including standardized use of measurement instruments, a standardized method of analysis, and individually tailored psychosocial, psychological and pharmacological treatment according to protocol. Primary outcomes: prevalence of behavioral problems (CMAI); quality of life (EQ-5D). Sample size calculation/data analysis. Sample size: 6 measurements on 14 dementia special care units (each with 20 residents on average) are needed (assumptions: BP prevalence 80%, effect 10 points decrease CMAI-score, almost no attrition, alpha 0.05, power 0.80, ICC 0.1). Data analysis: primary effects will be calculated using multilevel linear and logistic regression analyses. Prescription rate of antipsychotics and the EQ5D will be used in the primary analysis. Secondary analyses will include: prescription rate of antipsychotics; workload (burnout) and job satisfaction of nursing staff; use of restraints. Economic evaluation: from a healthcare perspective, two ICERs will be calculated for costs per: 1 one point decrease in CMAI-score; 2) one QALY increase. Time schedule: 48 months (21 months data collection).
Lay Summary
In which category does this research fall?
- Health and social care research
Managing behavioural problems in nursing home residents with dementia
Investments > €500k
Netherlands
Alzheimer’s disease & other dementias
2011